Search - tctmd.com

Displaying 201 - 220 of 636

Sort: Relevancy | Date

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

News Conference News ACC 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

March 04, 2023

Mountains of Cath Lab Waste Could Be Recycled, Study Estimates

News Conference News ACC 2023

Mountains of Cath Lab Waste Could Be Recycled, Study Estimates

March 01, 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

News Conference News ISC 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

February 17, 2023

AHA Issues Recommendations for Structuring Stroke Programs

News Conference News ISC 2023

AHA Issues Recommendations for Structuring Stroke Programs

February 16, 2023

Racial/Ethnic Disparities Persist in Treatment of Poststroke Complications

News Conference News ISC 2023

Racial/Ethnic Disparities Persist in Treatment of Poststroke Complications

February 15, 2023

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

News Conference News ISC 2023

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

February 14, 2023

Endovascular Therapy Works for Ischemic Strokes with Large Cores, Trials Affirm

News Conference News ISC 2023

Endovascular Therapy Works for Ischemic Strokes With Large Cores, Trials Affirm

February 13, 2023

Lower BP Targets After Stroke Thrombectomy Don’t Seem to Help: BEST-II

News Conference News ISC 2023

Lower BP Targets After Stroke Thrombectomy Don’t Seem to Help: BEST-II

February 10, 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

News Conference News ISC 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

February 10, 2023

Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke

News Conference News ISC 2023

Continuous Monitoring Finds AF Up to 3 Years After Noncryptogenic Stroke

February 08, 2023

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

News Conference News AHA 2022

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

November 14, 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

November 10, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

First-line Ablation Reduces AF Progression, Boosts Quality of Life

News Conference News AHA 2022

First-line Ablation Reduces AF Progression, Boosts Quality of Life

November 07, 2022

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

News Conference News AHA 2022

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

November 07, 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

November 06, 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

November 05, 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

November 05, 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

News Conference News HFSA 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

October 07, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.